Trial Profile
An Open-label, Single-dose, Non-randomized Study of the Absorption, Metabolism, and Excretion of Intravenously Administered 14C-labeled PER977 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 May 2020
Price :
$35
*
At a glance
- Drugs Ciraparantag (Primary)
- Indications Haemorrhage
- Focus Pharmacokinetics
- Sponsors Perosphere
- 25 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Aug 2014 New trial record